Search
Now showing items 1-2 of 2
Prevalence of specific neutralizing antibodies against Sendai virus in populations from different geographic areas Implications for AIDS vaccine development using Sendai virus vectors
(2011-06)
A Sendai Virus (Sev) vector is being developed for an HIV immunogen. SeV is not known to cause disease in humans. Because it is genetically and antigenically related to human parainfluenza virus type 1 (hPIV-1), it is ...
What impact would an HIV/AIDS vaccine have on the HIV/AIDS epidemic in Kenya?
(2012-09)
Objective: To estimate the potential impact of an HIV/AIDS Vaccine in Kenya. Design: The Kenyan HIV/AIDS epidemic was modeled using the most current data from national sources including epidemiology and behavioral surveillance. ...